Biora Therapeutics, Inc. Bankruptcy Docket

Cases

Converted to Chapter 7 on May 27, 2025

Updated Oct 4, 4:19 AM ET

Petition filed
Dec 27, 2024
Converted to Chapter 7
May 27, 2025

Biora Therapeutics entered Chapter 7 liquidation on May 27, 2025, following the March 7 closing of its principal asset sale, reported in counsel’s final fee application Dkt. 229. The conversion order Dkt. 269 directed the transfer of books, records and claims information to the Chapter 7 trustee, placing the remaining estate on a trustee-administered liquidation path.

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Our analysis

Biora Therapeutics: 363 Sale Followed by Chapter 7 Conversion · Mar 6, 2026

Key firms

McDermott Will & Schulte LLPBankruptcy Counsel
Pachulski Stang Ziehl & Jones LLPBankruptcy Counsel
MTS Health Partners, L.P.Investment Banker
Evora Partners, LLCOperations Management Advisor

Recent filings

May 27Order Converting Case to Chapter 7Bankr. D. Del., No. 24-12849, ECF No. 269Dkt. 269
May 27Affidavit/Declaration of Mailing of Eladio Perez Regarding Notice of Further Rescheduled Hearing with Respect to Motion of Debtor for Entry of Order Converting the Chapter 11 Case to a Case Under Chapter 7 of the Bankruptcy Code and Granting Related Relief, Notice of Agenda of Matters Scheduled for Hearing on May 21, 2025 at 1:30 p.m. (ET), before the Honorable Brendan Linehan Shannon, at the United States Bankruptcy Court for the District of Delaware, 824 North Market Street, 6th Floor, Courtroom No. 1, Wilmington, Delaware 19801, and Notice of Staffing and Compensation Report of Evora Partners, LLC for the Period from April 1, 2025 through April 30, 2025. Filed by Kroll Restructuring Administration LLC. (related document(s)259, 260, 261)Bankr. D. Del., No. 24-12849, ECF No. 270Dkt. 270
May 27Appointment of Trustee -Alfred T. Giuliano Filed by U.S. Trustee.Bankr. D. Del., No. 24-12849, ECF No. 272Dkt. 272
May 22Hearing Agenda for May 28, 2025Bankr. D. Del., No. 24-12849, ECF No. 267Dkt. 267
May 21Chapter 11 Monthly Operating Report for the Month Ending: 04/30/2025 Filed by Biora Therapeutics, Inc..Bankr. D. Del., No. 24-12849, ECF No. 265Dkt. 265
May 20Affidavit/Declaration of Mailing of Engels Medina Regarding Notice of Filing of Supplement to First and Final Fee Application of McDermott Will & Emery LLP, Counsel to the Debtor and Debtor in Possession, for Allowance of Compensation and Reimbursement of Expenses for the Case Period from December 27, 2024, through and Including the Final Fee Application Hearing. Filed by Kroll Restructuring Administration LLC. (related document(s)251)Bankr. D. Del., No. 24-12849, ECF No. 264Dkt. 264

Full docket (352) →

Case facts and filing dates come from court records.

Converted to Chapter 7 on May 27, 2025

Updated Oct 4, 4:19 AM ET

Petition filed
Dec 27, 2024
Converted to Chapter 7
May 27, 2025

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Our analysis

Biora Therapeutics: 363 Sale Followed by Chapter 7 Conversion · Mar 6, 2026

Key firms

McDermott Will & Schulte LLPBankruptcy Counsel
Pachulski Stang Ziehl & Jones LLPBankruptcy Counsel
MTS Health Partners, L.P.Investment Banker
Evora Partners, LLCOperations Management Advisor

Recent filings

May 27Order Converting Case to Chapter 7Bankr. D. Del., No. 24-12849, ECF No. 269Dkt. 269
May 27Affidavit/Declaration of Mailing of Eladio Perez Regarding Notice of Further Rescheduled Hearing with Respect to Motion of Debtor for Entry of Order Converting the Chapter 11 Case to a Case Under Chapter 7 of the Bankruptcy Code and Granting Related Relief, Notice of Agenda of Matters Scheduled for Hearing on May 21, 2025 at 1:30 p.m. (ET), before the Honorable Brendan Linehan Shannon, at the United States Bankruptcy Court for the District of Delaware, 824 North Market Street, 6th Floor, Courtroom No. 1, Wilmington, Delaware 19801, and Notice of Staffing and Compensation Report of Evora Partners, LLC for the Period from April 1, 2025 through April 30, 2025. Filed by Kroll Restructuring Administration LLC. (related document(s)259, 260, 261)Bankr. D. Del., No. 24-12849, ECF No. 270Dkt. 270
May 27Appointment of Trustee -Alfred T. Giuliano Filed by U.S. Trustee.Bankr. D. Del., No. 24-12849, ECF No. 272Dkt. 272
May 22Hearing Agenda for May 28, 2025Bankr. D. Del., No. 24-12849, ECF No. 267Dkt. 267
May 21Chapter 11 Monthly Operating Report for the Month Ending: 04/30/2025 Filed by Biora Therapeutics, Inc..Bankr. D. Del., No. 24-12849, ECF No. 265Dkt. 265
May 20Affidavit/Declaration of Mailing of Engels Medina Regarding Notice of Filing of Supplement to First and Final Fee Application of McDermott Will & Emery LLP, Counsel to the Debtor and Debtor in Possession, for Allowance of Compensation and Reimbursement of Expenses for the Case Period from December 27, 2024, through and Including the Final Fee Application Hearing. Filed by Kroll Restructuring Administration LLC. (related document(s)251)Bankr. D. Del., No. 24-12849, ECF No. 264Dkt. 264

Full docket (352) →

Case facts and filing dates come from court records.